Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |